Summarized by Masters of Longevity from Fight Aging!.
Early human safety data and preclinical cellular-reprogramming advances — a newsletter-style update summarizing clinical and lab developments readers will explore.
Key Takeaways
- A single intravitreal OSK injection with oral doxycycline was well tolerated through Day 56.
- Two of three glaucoma participants had Humphrey Visual Field improvements exceeding four decibels.
- LNP-delivered mRNA reprogrammed about eighty percent of targeted NK cells in mice.
